drugset / Trial / NCT01159119

A Study of EUR-1066 in Subjects With Chronic Pancreatitis, Exocrine Pancreatic Insufficiency and Chronic Abdominal Pain

NCT01159119

Phase 1 Terminated 15 enrolled Forest Laboratories University of Florida · collab
RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of this study is to evaluate two different treatments in subjects with chronic pancreatitis, exocrine pancreatic insufficiency and chronic abdominal pain.

Timeline

Start
2010-08-02
Primary completion
2011-07-01
Completion
2011-07-01

Drugs

EvaluationDrugModalityDoseRoute
Subject EUR-1066-A Protein / enzyme biologic
Subject EUR-1066-B Protein / enzyme biologic
Comparator Pancrelipase Protein / enzyme biologic

Indications